Pharmaceuticals, da Silva (Gilead): ""Over 18 million invested in 15 years to support 800 projects

"Over 15 years, Gilead has supported approximately 800 projects, investing over €18 million and involving more than 5.000 patients and caregivers. Public-private collaboration and research are essential to transforming innovation into concrete benefits for patients," said Frederico da Silva, Vice President & General Manager of Gilead Sciences Italy, at the meeting "Generating Innovation.

“Creating Health” promoted by Gilead, in Rome.

https://www.youtube.com/watch?v=6YfXING4-J8

Continue on the app The news of your city, in real time.

Open in app

Interlagos 2026: Stats, Trivia, and Schumacher's Race to a Record

Peru, the city considered cursed for centuries awaits Pope Leo XIV

Pope Leo, the announcement comes just now: "After cancer, he decided..."

Midterm, Kallas: US voters have spoken clearly

Milan's embrace for Rkomi, a successful first date of the tour.

Prix Galien Italia to MSD for new tools in the prevention and treatment of rare diseases.

Battacone (UniSS), "Pulina explains animal husbandry in ten lessons accessible to all."

"We are convinced of one thing," the Garlasco case: Napoleon's words to Alberto Stasi

Pharmaceuticals, Murzi (J&J): "In Italy, there are over 127 active clinical trials and 7.500 patients involved."

Rosati (EAAP), "AI improves animal welfare, but it shouldn't alienate farmers and animals."

Pharmaceuticals, da Silva (Gilead): ""Over 18 million invested in 15 years to support 800 projects

Green Deal: Diesel is now strategic for the EU

Healthcare, Radovanovic (UniMi): "RSV vaccine reduces hospitalizations and serious events."

Carnimeo (Ecopneus), "the circular economy is the result of teamwork"

Iacono (Hera): "Forward with the transition, it's an investment in the country's competitiveness."

Fava (Ecomondo): "A complex year, with geopolitical implications."

Ronchi (Sustainable Development Foundation): "The Green Deal narrative is flawed, the transition is unavoidable."